Sign In
16 May 2022 07:00
LungLife AI, Inc.
("LungLife" or the "Company")
Block Listing Six Monthly Return
LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, makes the following six monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies:
Name of applicant: | LungLife AI, Inc. | |||
Name of scheme: | 1. 2010 Stock Incentive Plan 2. 2020 Stock Incentive Plan 3. 2021 Omnibus Long-Term Incentive Plan | |||
Number and class of securities originally admitted: | 1,356,139 common shares of US $0.0001 each | |||
Date of admission: | 15 November 2021 | |||
Period of return: | From: | 15 November 2021 | To: | 15 May 2022 |
Balance of unallotted securities under scheme(s) from previous return: | 1. 480,775 2. 201,374 3. 673,990 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 1. NIL 2. NIL 3. NIL | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 1. NIL 2. NIL 3. NIL | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1. 480,775 2. 201,374 3. 673,990 | |||
Total number of securities in issue at the end of the period | 25,480,790 | |||
Name of contact: | David Anderson, Chief Financial Officer |
Telephone number of contact: | +44 (0)20 7933 8780 or lunglifeai@walbrookpr.com |
For further information please contact:
LungLife AI, Inc. | www.lunglifeai.com |
Paul Pagano, CEO | Via Walbrook PR |
David Anderson, CFO |
|
|
|
Investec Bank plc (Nominated Adviser & Broker) | Tel: +44 (0)20 7597 5970 |
Daniel Adams / Virginia Bull / Cameron MacRitchie | |
Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or LungLifeAI@walbrookpr.com |
Paul McManus / Alice Woodings | Mob: 07980 541 893 / 07407 804 654 |
Follow the stocks
